Therese M-L Andersson
Overview
Explore the profile of Therese M-L Andersson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
2111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stannard R, Lambert P, Lyratzopoulos G, Andersson T, Khan S, Rutherford M
Br J Cancer
. 2024 Dec;
PMID: 39674825
Monitoring trends of cancer incidence, mortality and survival is vital for the planning and delivery of health services, and the evaluation of diagnostics and treatment at the population level. Furthermore,...
2.
Lundberg F, Ekman S, Johansson A, Engholm G, Birgisson H, Olafsdottir E, et al.
Lung Cancer
. 2024 May;
192:107826.
PMID: 38795460
Objectives: The aim of this study was to evaluate if the previously reported improvements in lung cancer survival were consistent across age at diagnosis and by lung cancer subtypes. Materials...
3.
Palshof F, Morch L, Koster B, Engholm G, Storm H, Andersson T, et al.
Sci Rep
. 2024 Apr;
14(1):8577.
PMID: 38615059
Most Western countries have increasing number of new cancer cases per year. Cancer incidence is primarily influenced by basically avoidable risk factors and an aging population. Through hypothetical elimination scenarios...
4.
Johansson A, Konig S, Laronningen S, Engholm G, Kroman N, Seppa K, et al.
Acta Oncol
. 2024 Apr;
63:179-191.
PMID: 38597666
Background: Since the early 2000s, overall and site-specific cancer survival have improved substantially in the Nordic countries. We evaluated whether the improvements have been similar across countries, major cancer types,...
5.
Landtblom A, Andersson T, Johansson A, Lundberg F, Samuelsson J, Bjorkholm M, et al.
Leukemia
. 2024 Mar;
38(5):1081-1085.
PMID: 38461191
Myeloproliferative neoplasms (MPN) are associated with inferior pregnancy outcome, however, little is known about fertility and childbearing potential in women with MPN. In this study we aimed to describe reproductive...
6.
Lundberg F, Birgisson H, Engholm G, Olafsdottir E, Morch L, Johannesen T, et al.
Eur J Cancer
. 2024 Mar;
202:113980.
PMID: 38452724
Background: The survival in patients diagnosed with cutaneous malignant melanoma (CMM) has improved in the Nordic countries in the last decades. It is of interest to know if these improvements...
7.
Osterman E, Syriopoulou E, Martling A, Andersson T, Nordenvall C
Eur J Cancer
. 2024 Feb;
201:113940.
PMID: 38383167
No abstract available.
8.
Osterman E, Syriopoulou E, Martling A, Andersson T, Nordenvall C
Eur J Cancer
. 2024 Jan;
199:113572.
PMID: 38280280
Background: The introduction of national guidelines should eliminate previously observed associations between socioeconomic status (SES) and colorectal cancer treatment. The aim of the study was to investigate whether inequalities remain....
9.
Vikstrom S, Syriopoulou E, Andersson T, Eriksson H
J Am Acad Dermatol
. 2024 Jan;
90(5):963-969.
PMID: 38218560
Background: Survival in cutaneous melanoma (CM) is heterogeneous. Loss in life expectancy (LLE) measures impact of CM on remaining lifespan compared to general population. Objectives: Investigating LLE in operated stage...
10.
Leontyeva Y, Lambe M, Bower H, Lambert P, Andersson T
BMC Med Res Methodol
. 2023 Dec;
23(1):291.
PMID: 38087236
Purpose: This study introduces a novel method for estimating the variance of life expectancy since diagnosis (LE) and loss in life expectancy (LLE) for cancer patients within a relative survival...